hyperpituitarism: Disease of the glandular, anterior portion of the pituitary (pituitary gland, anterior) resulting in hypersecretion of adenohypophyseal hormones such as growth hormone; prolactin; thyrotropin; luteinizing hormone; follicle stimulating hormone ; and adrenocorticotropic hormone. Hyperpituitarism usually is caused by a functional adenoma.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
473681 |
1. Apply sex-specific ruleNone |
473681 |
2. Check conditionsNone |
473681 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1662 |
4. Check minimum number of eventsNone |
1662 |
5. Include endpoints |
1832 |
6. Filter based on genotype QC (FinnGen only) |
1736 |
Control definitions (FinnGen only)
Extra metadata
Similar endpoints
↥List of similar endpoints to Hyperfunction of pituitary gland based on the number of shared cases.
Similar with more cases:
- Disorders of other endocrine glands
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 13775 | 10007 | 3602 |
Only index persons | 12382 | 9265 | 3117 |
Unadjusted period prevalence (%) | |||
Whole population | 0.24 | 0.29 | 0.10 |
Only index persons | 0.28 | 0.34 | 0.12 |
Median age at first event (years) | |||
Whole population | 36.03 | 32.93 | 44.58 |
Only index persons | 35.04 | 32.51 | 42.55 |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 1736 | 1326 | 410 |
Unadjusted period prevalence (%) | 0.45 | 0.52 | 0.21 |
Median age at first event (years) | 38.04 | 34.33 | 50.03 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Mortality – FinRegistry
↥Association
Association between endpoint E4_HYPERPIT and mortality.
Females
Parameter | HR [95% CI] | p-value |
---|---|---|
E4_HYPERPIT | 1.864 [1.59, 2.18] | < 0.001 |
Birth year | 0.996 [0.99, 1.0] | 0.314 |
During the follow-up period (1.1.1998 — 31.12.2019), 660 out of 7880 females with E4_HYPERPIT died.
Males
Parameter | HR [95% CI] | p-value |
---|---|---|
E4_HYPERPIT | 1.915 [1.63, 2.25] | < 0.001 |
Birth year | 0.99 [0.98, 1.0] | 0.036 |
During the follow-up period (1.1.1998 — 31.12.2019), 521 out of 2276 males with E4_HYPERPIT died.
Mortality risk
Mortality risk for people of age
years, who have E4_HYPERPIT.N-year risk | Females | Males |
---|---|---|
1 | 0.217% | 0.38% |
5 | 1.083% | 2.337% |
10 | 2.632% | 6.055% |
15 | 5.096% | 10.909% |
20 | 9.329% | 18.171% |
Relationships between endpoints
↥Index endpoint: E4_HYPERPIT – Hyperfunction of pituitary gland
GWS hits: -